The global vaccine delivery devices market size is expected to reach USD 11,507.5 million by 2030, registering a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The market is primarily driven by growing immunization programs, financial support from government and non-government organizations, increasing vaccination initiatives and campaigns, and the rising prevalence of infectious diseases globally. Growing research in the field of vaccines and the development of new products are also contributing to the growth of the market.
The adoption of a needle-free approach for administering these products is gaining momentum due to the growing awareness and demand to avoid pain and injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling the market growth. The rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.
The Covid-19 epidemic significantly boosted the market growth, especially due to the increasing demand for vaccination to tackle the spread of the virus. Increasing investment in Research & Development by vaccination device manufacturers as well as the governments has expanded the market significantly at an accelerated pace. Initiatives are undertaken by various regulatory authorities like UNICEF, Gavi, and WHO are also expected to boost the market growth.
Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the U.K. government also announced funding of up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and the WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.
Request a free sample copy or view the report summary: Vaccine Delivery Devices Market Report
By device, the syringes segment held the largest revenue share in 2022 due to the increasing vaccination programs, spreading immunization coverage, and technological advancements
By route of administration, intradermal vaccination dominated the market in 2022 as the majority of vaccines are given through this route owing to its advantages
North America dominated the global market in 2022 owing to the increasing awareness levels, high adoption of technology, and the rising prevalence of infectious diseases
Grand View Research has segmented the global vaccine delivery devices market on the basis of device, route of administration, and region:
Vaccine Delivery Devices Outlook (Revenue, USD Million, 2018 - 2030)
Syringes
Jet Injectors
Other Devices
Vaccine Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Other Vaccinations
Vaccine Delivery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Vaccine Delivery Devices Market
Becton Dickinson & Company
Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
PharmaJet
Vaxxas
Gerresheimer AG
SCHOTT AG
Corium International, Inc.
3M
"The quality of research they have done for us has been excellent..."